Table 2 Successful home administration of evolocumab in THOMAS-1 and THOMAS-2
From: Evolocumab lowers LDL-C safely and effectively when self-administered in the at-home setting
THOMAS-1 | THOMAS-2 | |||
|---|---|---|---|---|
Autoinjector (n = 74) | PFS (n = 75) | Autoinjector (n = 82) | AMD (n = 82) | |
First administrationa | ||||
No. successful administrations | 71 | 73 | 77 | 78 |
% (95 % CI) | 95.9 (88.7, 98.6) | 97.3 (90.8, 99.3) | 93.9 (86.5, 97.4) | 95.1 (88.1, 98.1) |
Second administrationb | ||||
No. successful administrations | 68 | 72 | 76 | 79 |
% (95 % CI) | 91.9 (83.4, 96.2) | 96.0 (88.9, 98.6) | 92.7 (84.9, 96.6) | 96.3 (89.8, 98.7) |